Protagonist Therapeutics Inc (PTGX)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 434,433 | 60,000 | 26,581 | 27,357 | 28,628 |
| Property, plant and equipment | US$ in thousands | — | — | 1,565 | 6,734 | 1,462 |
| Fixed asset turnover | — | — | 16.98 | 4.06 | 19.58 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $434,433K ÷ $—K
= —
The fixed asset turnover ratio measures how efficiently a company generates revenue from its fixed assets. In the case of Protagonist Therapeutics Inc, the trend in the fixed asset turnover ratio shows fluctuations over the years.
The ratio was relatively high at 19.58 as of December 31, 2020, indicating that the company generated significant revenue relative to its investment in fixed assets. However, the ratio dropped to 4.06 by December 31, 2021, suggesting a decrease in the efficiency of generating revenue from fixed assets.
Subsequently, the ratio improved to 16.98 by December 31, 2022, indicating a more efficient use of fixed assets to generate revenue. Unfortunately, data for December 31, 2023, and December 31, 2024 are unavailable (marked as "—"), making it challenging to provide a complete analysis for those periods.
Overall, Protagonist Therapeutics Inc's fixed asset turnover ratio has shown fluctuations, highlighting the importance of ongoing monitoring and management of fixed asset efficiency in generating revenue.
Peer comparison
Dec 31, 2024